These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 20005400
21. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy. Savikko J, Taskinen E, Von Willebrand E. Transplantation; 2003 Apr 27; 75(8):1147-53. PubMed ID: 12717194 [Abstract] [Full Text] [Related]
22. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1993 Sep 27; 422():1-340. PubMed ID: 12616289 [Abstract] [Full Text] [Related]
23. Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy. Luo L, Sun Z, Wu W, Luo G. BMC Nephrol; 2012 Jul 02; 13():53. PubMed ID: 22747784 [Abstract] [Full Text] [Related]
28. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection. Rintala SE, Savikko J, Rintala JM, von Willebrand E. Transplant Proc; 2006 Dec 02; 38(10):3236-8. PubMed ID: 17175233 [Abstract] [Full Text] [Related]
29. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes. Majoor GD, Van Breda Vriesman PJ. Transplantation; 1983 Feb 02; 35(2):121-6. PubMed ID: 6338632 [Abstract] [Full Text] [Related]
30. Urinary connective tissue growth factor increases far earlier than histopathological damage and functional deterioration in early chronic renal allograft injury. Shi Y, Tu Z, Bao J, Sun H, Wang W, Luo G, Li S, Li Y, Bu H. Scand J Urol Nephrol; 2009 Feb 02; 43(5):390-9. PubMed ID: 19921985 [Abstract] [Full Text] [Related]
31. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine. Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J. Transplant Proc; 2008 Dec 02; 40(10):3731-6. PubMed ID: 19100477 [Abstract] [Full Text] [Related]
32. Clinical application of Cordyceps sinensis on immunosuppressive therapy in renal transplantation. Li Y, Xue WJ, Tian PX, Ding XM, Yan H, Pan XM, Feng XS. Transplant Proc; 2009 Jun 02; 41(5):1565-9. PubMed ID: 19545680 [Abstract] [Full Text] [Related]
33. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury. Delbridge MS, Shrestha BM, Raftery AT, El Nahas AM, Haylor J. Transplant Proc; 2007 Dec 02; 39(10):2992-6. PubMed ID: 18089307 [Abstract] [Full Text] [Related]
34. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1994 Jan 02; 424():1-304. PubMed ID: 12616287 [Abstract] [Full Text] [Related]
35. Conversion from cyclosporine to mycophenolate mofetil improves expression of A20 in the rat kidney allografts undergoing chronic rejection. Teng D, Lu Y, Gao R, Xin Y, Cao G, Li X, Wang L, Wang J, Wang L, Li Y. Transplant Proc; 2006 Sep 02; 38(7):2164-7. PubMed ID: 16980032 [Abstract] [Full Text] [Related]
37. Down-regulation of TGF-beta and VCAM-1 is associated with successful treatment of chronic rejection in rats. Crews GM, Erickson L, Pan F, Fisniku O, Jang MS, Wynn C, Benediktsson H, Kobayashi M, Jiang H. Transplant Proc; 2005 May 02; 37(4):1926-8. PubMed ID: 15919506 [Abstract] [Full Text] [Related]
39. Protective effects of FR167653 on chronic allograft nephropathy by inhibiting p38 MAPK in rats. Tan HB, Feng Y, Liu M, Wu YC. Transplant Proc; 2008 Jun 02; 40(5):1685-9. PubMed ID: 18589173 [Abstract] [Full Text] [Related]